Gables Capital Management Inc. Astrazeneca PLC Transaction History

Gables Capital Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	SELL	$69.91 - $75.81 $2,446 - $2,653	-35 Reduced 12.28%	250 $17,000
Q1 2023 May 03, 2023	BUY	$63.15 - $71.6 $2,210 - $2,506	35 Added 14.0%	285 $19,000
Q3 2020 Nov 12, 2020	BUY	$53.07 - $61.1 $7,960 - $9,165	150 Added 150.0%	250 $14,000
Q2 2020 Jul 30, 2020	BUY	$43.1 - $55.31 $4,310 - $5,531	100 New	100 $5,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Gables Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Gables Capital Management Inc. with notifications on news.